Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Plasma pseudouridine levels reflect body size in children on hemodialysis.

O'Brien FJ, Sirich TL, Taussig A, Fung E, Ganesan LL, Plummer NS, Brakeman P, Sutherland SM, Meyer TW.

Pediatr Nephrol. 2019 Nov 14. doi: 10.1007/s00467-019-04369-6. [Epub ahead of print]

PMID:
31728748
2.

Asymmetric dimethylarginine, erythropoietin resistance, and anemia in CKD.

Sirich TL, Chertow GM.

Ann Transl Med. 2019 Jul;7(Suppl 3):S86. doi: 10.21037/atm.2019.04.22. No abstract available.

3.

Accumulation of uremic solutes in the cerebrospinal fluid in experimental acute renal failure.

Mair RD, Nguyen H, Huang TT, Plummer NS, Sirich TL, Meyer TW.

Am J Physiol Renal Physiol. 2019 Aug 1;317(2):F296-F302. doi: 10.1152/ajprenal.00100.2019. Epub 2019 May 29.

PMID:
31141401
4.

Blood Microbiome in CKD: Should We Care?

Mair RD, Sirich TL.

Clin J Am Soc Nephrol. 2019 May 7;14(5):648-649. doi: 10.2215/CJN.03420319. Epub 2019 Apr 8. No abstract available.

PMID:
30962188
5.

Contribution of 'clinically negligible' residual kidney function to clearance of uremic solutes.

Toth-Manikowski SM, Sirich TL, Meyer TW, Hostetter TH, Hwang S, Plummer NS, Hai X, Coresh J, Powe NR, Shafi T.

Nephrol Dial Transplant. 2019 Mar 15. pii: gfz042. doi: 10.1093/ndt/gfz042. [Epub ahead of print]

PMID:
30879076
6.

Timing of blood pressure medications and intradialytic hypotension.

Wang KM, Sirich TL, Chang TI.

Semin Dial. 2019 May;32(3):201-204. doi: 10.1111/sdi.12777. Epub 2019 Mar 5.

PMID:
30836447
7.

Characteristics of Colon-Derived Uremic Solutes.

Mair RD, Sirich TL, Plummer NS, Meyer TW.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1398-1404. doi: 10.2215/CJN.03150318. Epub 2018 Aug 7.

8.

Uremic Toxin Clearance and Cardiovascular Toxicities.

Mair RD, Sirich TL, Meyer TW.

Toxins (Basel). 2018 Jun 2;10(6). pii: E226. doi: 10.3390/toxins10060226. Review.

9.

Residual Function Effectively Controls Plasma Concentrations of Secreted Solutes in Patients on Twice Weekly Hemodialysis.

Leong SC, Sao JN, Taussig A, Plummer NS, Meyer TW, Sirich TL.

J Am Soc Nephrol. 2018 Jul;29(7):1992-1999. doi: 10.1681/ASN.2018010081. Epub 2018 May 4.

10.

Intensive Hemodialysis Fails to Reduce Plasma Levels of Uremic Solutes.

Sirich TL, Meyer TW.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):361-362. doi: 10.2215/CJN.00950118. Epub 2018 Feb 14. No abstract available.

11.

Untargeted mass spectrometry discloses plasma solute levels poorly controlled by hemodialysis.

Sirich TL, Aronov PA, Fullman J, Nguyen K, Plummer NS, Meyer TW.

PLoS One. 2017 Nov 16;12(11):e0188315. doi: 10.1371/journal.pone.0188315. eCollection 2017.

12.

Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.

Shafi T, Sirich TL, Meyer TW, Hostetter TH, Plummer NS, Hwang S, Melamed ML, Banerjee T, Coresh J, Powe NR.

Kidney Int. 2017 Dec;92(6):1484-1492. doi: 10.1016/j.kint.2017.05.012. Epub 2017 Jul 21.

13.

Obstacles to reducing plasma levels of uremic solutes by hemodialysis.

Sirich TL.

Semin Dial. 2017 Sep;30(5):403-408. doi: 10.1111/sdi.12609. Epub 2017 May 30.

PMID:
28558415
14.

Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.

Sirich TL, Fong K, Larive B, Beck GJ, Chertow GM, Levin NW, Kliger AS, Plummer NS, Meyer TW; Frequent Hemodialysis Network (FHN) Trial Group.

Kidney Int. 2017 May;91(5):1186-1192. doi: 10.1016/j.kint.2016.11.002. Epub 2017 Jan 12.

PMID:
28089366
15.

Manipulating the microbiome.

Sirich TL, Meyer TW.

Kidney Int. 2017 Feb;91(2):274-276. doi: 10.1016/j.kint.2016.10.016.

PMID:
28087007
16.

Indoxyl Sulfate-Review of Toxicity and Therapeutic Strategies.

Leong SC, Sirich TL.

Toxins (Basel). 2016 Nov 30;8(12). pii: E358. Review.

17.

Kt/Vurea and Nonurea Small Solute Levels in the Hemodialysis Study.

Meyer TW, Sirich TL, Fong KD, Plummer NS, Shafi T, Hwang S, Banerjee T, Zhu Y, Powe NR, Hai X, Hostetter TH.

J Am Soc Nephrol. 2016 Nov;27(11):3469-3478. Epub 2016 Mar 29.

18.

More Dialysis Has Not Proven Much Better.

O'Brien FJ, Fong KD, Sirich TL, Meyer TW.

Semin Dial. 2016 Nov;29(6):481-490. doi: 10.1111/sdi.12533. Epub 2016 Aug 24.

PMID:
27556575
19.

Metabolic Profiling of Impaired Cognitive Function in Patients Receiving Dialysis.

Kurella Tamura M, Chertow GM, Depner TA, Nissenson AR, Schiller B, Mehta RL, Liu S, Sirich TL; FHN Study.

J Am Soc Nephrol. 2016 Dec;27(12):3780-3787. Epub 2016 Jul 21.

20.

Effect of a sustained difference in hemodialytic clearance on the plasma levels of p-cresol sulfate and indoxyl sulfate.

Camacho O, Rosales MC, Shafi T, Fullman J, Plummer NS, Meyer TW, Sirich TL.

Nephrol Dial Transplant. 2016 Aug;31(8):1335-41. doi: 10.1093/ndt/gfw100. Epub 2016 May 17.

PMID:
27190347
21.

Uremic Solutes Produced by Colon Microbes.

Tanaka H, Sirich TL, Meyer TW.

Blood Purif. 2015;40(4):306-11. doi: 10.1159/000441578. Epub 2015 Nov 17.

22.

Tubular Secretion in CKD.

Suchy-Dicey AM, Laha T, Hoofnagle A, Newitt R, Sirich TL, Meyer TW, Thummel KE, Yanez ND, Himmelfarb J, Weiss NS, Kestenbaum BR.

J Am Soc Nephrol. 2016 Jul;27(7):2148-55. doi: 10.1681/ASN.2014121193. Epub 2015 Nov 27.

23.

An Enlarged Profile of Uremic Solutes.

Tanaka H, Sirich TL, Plummer NS, Weaver DS, Meyer TW.

PLoS One. 2015 Aug 28;10(8):e0135657. doi: 10.1371/journal.pone.0135657. eCollection 2015.

24.

Dietary protein and fiber in end stage renal disease.

Sirich TL.

Semin Dial. 2015 Jan-Feb;28(1):75-80. doi: 10.1111/sdi.12315. Epub 2014 Oct 16.

PMID:
25319504
25.

Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients.

Sirich TL, Plummer NS, Gardner CD, Hostetter TH, Meyer TW.

Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1603-10. doi: 10.2215/CJN.00490114. Epub 2014 Aug 21.

26.

Protein-bound molecules: a large family with a bad character.

Sirich TL, Meyer TW, Gondouin B, Brunet P, Niwa T.

Semin Nephrol. 2014 Mar;34(2):106-17. doi: 10.1016/j.semnephrol.2014.02.004. Epub 2014 Feb 18.

PMID:
24780467
27.

Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study.

Niewczas MA, Sirich TL, Mathew AV, Skupien J, Mohney RP, Warram JH, Smiles A, Huang X, Walker W, Byun J, Karoly ED, Kensicki EM, Berry GT, Bonventre JV, Pennathur S, Meyer TW, Krolewski AS.

Kidney Int. 2014 May;85(5):1214-24. doi: 10.1038/ki.2013.497. Epub 2014 Jan 15.

28.

Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion.

Sirich TL, Funk BA, Plummer NS, Hostetter TH, Meyer TW.

J Am Soc Nephrol. 2014 Mar;25(3):615-22. doi: 10.1681/ASN.2013060597. Epub 2013 Nov 14.

29.

Numerous protein-bound solutes are cleared by the kidney with high efficiency.

Sirich TL, Aronov PA, Plummer NS, Hostetter TH, Meyer TW.

Kidney Int. 2013 Sep;84(3):585-90. doi: 10.1038/ki.2013.154. Epub 2013 May 1.

30.

Selectively increasing the clearance of protein-bound uremic solutes.

Sirich TL, Luo FJ, Plummer NS, Hostetter TH, Meyer TW.

Nephrol Dial Transplant. 2012 Apr;27(4):1574-9. doi: 10.1093/ndt/gfr691. Epub 2012 Jan 9.

31.

Dialysis cannot be dosed.

Meyer TW, Sirich TL, Hostetter TH.

Semin Dial. 2011 Sep-Oct;24(5):471-9. doi: 10.1111/j.1525-139X.2011.00979.x. Epub 2011 Sep 19.

32.

A strategy for the determination of enzyme kinetics using electrospray ionization with an ion trap mass spectrometer.

Ge X, Sirich TL, Beyer MK, Desaire H, Leary JA.

Anal Chem. 2001 Nov 1;73(21):5078-82.

PMID:
11721902

Supplemental Content

Loading ...
Support Center